Calendar Tuesday, November 13, 2018 Interim Report Q3 2018 read more News Conference Call read more Investor Conference Call read more Calendar Overview Can We Live Better? Will old age stop us seeing our grandkids? Read more Can We Live Better? Could the world’s fresh water supply dry up? Read more Can We Live Better? Should being healthy rely on more than hope? Read more Can We Live Better? How do you fight an enemy with many faces? Read more Can We Live Better? Can he bring you more years? Read more Career DevelopmentA Year Abroad with BayerRead more Synthetic BiologyCould We Replace Artificial Fertilizer?Read more Bayer & MonsantoNow Advancing Together as OneRead more Show more Our Amazing BrainHow B Vitamins Boost your BrainRead more Bee HealthLearning Our ABC’s About PollinatorsRead more Cooperation with myAgro StartupBetter Harvests and Healthy FamiliesRead more Q2 | 2018 Interim ReportBayer Completes Biggest Acquisition in its HistoryRead more UVA & UVB RaysProtecting the Skin properlyRead more New TechnologiesFarm of the FutureRead more Allergies & AsthmaAre you Allergic to your own Home?Read more Emphasis SoilCrop Production and BiodiversityRead more Women's HealthThe Misconception of Heart DiseaseRead more Crop Science Transparency InitiativeMaking Safety Studies AccesibleRead more Farm Meets TableThe Smart Farming RevolutionRead more NeuroscienceFood for the Mind: MicronutrientsRead more Medicinal PlantsNew Uses for Ancient Active SubstancesRead more Human-Animal BondDo Pets Improve our Health?Read more Bee HealthLearning Our ABC’s About PollinatorsRead more ImmunotherapiesUnleashing the Immune Response to CancerRead more Arabica, Robusta & Co.Where's my Coffee Coming from?Read more Producing a Beloved FruitTwo Apples a Day…Read more High-potency Active Ingredients“High Potentials” to Combat DiseasesRead more Bayer MagazineA Text message Against HungerRead more New Therapy ApproachesTreating Hemophilia with Gene SurgeryRead more Bayer Corporate BlogHow Self-care Helped Save my LifeRead more Bayer Corporate BlogA Strong Brand Can’t Rest on its LaurelsRead more Meet our ScientistsHere's How to Improve Photosynthesis in PlantsRead more Bayer Annual Report 2017Business at prior-year level - on track with strategyRead more Fighting CancerGaining TimeRead more Challenges in AgricultureTwo Farmers, Two WorldsRead more Extra ProtectionOur Skin Needs Special CareRead more Ticks & FleasHow Special Collars Can Protect Cats & DogsRead more Bayer Corporate Blog"I Found My Calling in Agriculture"Read more For A Better LifeOur Brand.Read more Zika SyndromeThe Virus FighterRead more Novel TherapiesSmall Molecules to Treat CancerRead more Working at BayerAn Exciting Place for EngineersRead more Food ProductionStopping Crop LossesRead more SustainabilityHow Is Bayer Responding to Climate Change?Read more Bee HealthCombating Parasites in the BeehiveRead more Oncology ResearchFighting CancerRead more Future of AgricultureSmart FieldsRead more Cancer TherapiesA Few Months Can Be Worth A LotRead more TechnologyWhat Is Bayer’s Position on Genetic Engineering?Read more Support For Smallholder FarmersBayer & NGOs CollaborateRead more OptogeneticsControlling Cells with Light SignalsRead more Links Information for Patients Sports Modern Slavery Act Statement (PDF, 1.05 MB) Latest News Share Price / Index October 24, 2018 Not intended for U.S. and UK Media Phase III trial of darolutamide in patients with non-metastatic castration-resistant prostate cancer meets primary endpointRead more October 21, 2018 Not intended for U.S. and UK Media - ESMO 2018 Congress (European Society for Medical Oncology) Expanded larotrectinib data confirm findings on efficacy and safety in adult and pediatric patients with TRK fusion cancer across various tumor typesRead more October 12, 2018 Not intended for U.S. and UK Media U.S. FDA approves Bayer’s Xarelto® for patients with coronary or peripheral artery diseaseRead moreNews Overview Advance Your Career Career Why Bayer Read more Working at Bayer Meet Our Employees Read more Open Jobs Explore Our Businesses We address some of the world's most pressing global challenges and continue to develop new solutions. The population is constantly growing and its age is increasing. That is why it needs better medicines and high-quality food in sufficient quantities. Learn more about it here. Pharmaceuticals Read more Consumer Health Read more Crop Science Read more Animal Health Read more Find Your Product With our products we contribute to the health of people, animals and plants. Here you find an overview of the major Bayer products. A Allergy Analgesics Angiography Bacterial Infections Canola Seed Cardiology Companion Animals Computed Tomography Cotton Seed Cough & Cold Dermatology Diabetes Digestive Health Farm Animals Foot Care Fungicides Hematology Herbicides Injection Systems Insecticides Magnetic Resonance Tomography Men's Healthcare Neurological diseases Nutritionals Oncology Ophthalmology PET Infusion System Pulmonary Hypertension Rice Seed Seeds Soybean Seed Sun Care Thromboembolic diseases Traits Vector Control Vegetable Seeds Women´s Healthcare Animal Health Consumer Health Crop Protection Digital Farming Environmental Science Pharmaceuticals Radiology Seeds & Traits All products Z Can We Live Better? Challenges of a Better Tomorrow Aging Population, big data, prenatal nutrition, water scarcity, animal-human bond: Bayer engages in a conversation about the future that matters the most to you – your own. Read more
October 24, 2018 Not intended for U.S. and UK Media Phase III trial of darolutamide in patients with non-metastatic castration-resistant prostate cancer meets primary endpointRead more
October 21, 2018 Not intended for U.S. and UK Media - ESMO 2018 Congress (European Society for Medical Oncology) Expanded larotrectinib data confirm findings on efficacy and safety in adult and pediatric patients with TRK fusion cancer across various tumor typesRead more
October 12, 2018 Not intended for U.S. and UK Media U.S. FDA approves Bayer’s Xarelto® for patients with coronary or peripheral artery diseaseRead more